SNYRQOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Synergy CHC Corp.
Financials through Q1 FY2026, quarter ended Mar 31, 2026Last filing: 10-Q on May 14, 2026
$0.01+0.00 (+5.26%)
Close on Oct 19, 2026
- Market cap
- $90.43K
- P/E (TTM)
- –
- Dividend yield
- –
Synergy CHC statistics
Financials through Mar 31, 2026, price as of Oct 19, 2026, median of Medicinal Chemicals & Botanical Products companies for comparison
Valuation
| Measure | Synergy CHC | Industry median |
|---|---|---|
| Market Cap | $119.20K | $166.30M |
| Enterprise Value | $24.85M | $88.19M |
| PS Ratio | 0.00 | 3.65 |
Enterprise value
| Measure | Synergy CHC | Industry median |
|---|---|---|
| EV / Sales | 0.90 | 2.51 |
Income (trailing twelve months)
| Measure | Synergy CHC | Industry median |
|---|---|---|
| Revenue | $27.70M | $58.34M |
| Gross Profit | $18.11M | $105.94M |
| Operating Income | -$10.97M | -$21.40M |
| Pretax Income | -$15.67M | -$14.34M |
| Net Income | -$15.79M | -$22.46M |
| EBITDA | -$10.84M | -$16.91M |
| EPS (Diluted) | -$1.36 | -$0.83 |
Margins
| Measure | Synergy CHC | Industry median |
|---|---|---|
| Gross Margin | 65.4% | 52.9% |
| Operating Margin | -39.6% | -44.0% |
| Pretax Margin | -56.6% | -13.3% |
| Profit Margin | -57.0% | -40.2% |
| EBITDA Margin | -39.1% | -30.2% |
Returns
| Measure | Synergy CHC | Industry median |
|---|---|---|
| Return on Assets (ROA) | -142.7% | -40.9% |
Growth
| Measure | Synergy CHC | Industry median |
|---|---|---|
| Revenue Growth (YoY) | -17.5% | 5.96% |
| Net Income Growth (YoY) | -752.1% | -35.2% |
| EPS Growth (YoY) | -538.7% | -26.2% |
| Revenue Growth (5Y CAGR) | -2.12% | 6.48% |
Balance sheet
| Measure | Synergy CHC | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $292.12K | $61.43M |
| Total Debt | $25.02M | $118.52M |
| Net Cash (Debt) | -$24.73M | $15.35M |
| Net Cash Per Share | -$1.66 | $0.66 |
| Equity (Book Value) | -$25.41M | $49.09M |
| Book Value Per Share | -$1.71 | $1.37 |
| Tangible Book Value | -$25.52M | $23.52M |
| Working Capital | -$503.86K | $76.81M |
Financial position
| Measure | Synergy CHC | Industry median |
|---|---|---|
| Current Ratio | 0.93 | 3.34 |
| Quick Ratio | 0.23 | 2.44 |
| Interest Coverage | -1.60 | -6.26 |
Cash flow (trailing twelve months)
| Measure | Synergy CHC | Industry median |
|---|---|---|
| Operating Cash Flow | -$3.81M | -$12.35M |
Efficiency
| Measure | Synergy CHC | Industry median |
|---|---|---|
| Asset Turnover | 2.51 | 0.39 |
| Inventory Turnover | 3.35 | 2.70 |
| Revenue Per Employee | $989.39K | $404.87K |
| Profits Per Employee | -$563.80K | -$703.34K |
| Employee Count | 28 | 74 |
Dividends and yields
| Measure | Synergy CHC | Industry median |
|---|---|---|
| Earnings Yield | -13243.7% | -23.3% |
Shares
| Measure | Synergy CHC | Industry median |
|---|---|---|
| Shares Outstanding | 14,899,900 | 58,127,000 |
| Shares Change (YoY) | 31.2% | 10.9% |
| Shares Change (QoQ) | 0.00% | 0.54% |
| Float | 7,751,490 | 49,136,700 |
| Shares Held by Insiders | 48.0% | 11.6% |
| Shares Held by Institutions | 3.96% | 59.4% |
Taxes
| Measure | Synergy CHC | Industry median |
|---|---|---|
| Income Tax | $115.21K | $79.87K |
Scores
| Measure | Synergy CHC | Industry median |
|---|---|---|
| Altman Z-Score | -14.19 | -0.22 |
| Piotroski F-Score | 2 | 4 |
Calculated by StockData from Synergy CHC's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.